<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(7)</volume><submitter>Srivastava A</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Carcinoma of gallbladder (GBC) is an aggressive malignancy. The higher incidence of gallbladder cancer in women has been partly attributed to hormonal factors. Therefore the present study was designed to explore the role of genetic variants in estrogen (ESR1, ESR2) and progesterone (PGR) receptors in conferring risk of gallbladder cancer.&lt;h4>Materials and methods&lt;/h4>The present case-control study recruited total of 860 subjects, including 410 GBC patients, 230 gallstone patients and 220 controls. We examined the associations of 6 selected polymorphisms in three genes: ESR1 (rs2234693, rs9340799, rs1801132), ESR2 (rs1271572, rs1256049) and PGR (rs1042838) with GBC risk. Genotyping for all the polymorphisms was done using PCR-RFLP. Multifactor dimensionality reduction and</pubmed_abstract><journal>PloS one</journal><pagination>e40162</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3393738</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy.</pubmed_title><pmcid>PMC3393738</pmcid><pubmed_authors>Mittal B</pubmed_authors><pubmed_authors>Sharma KL</pubmed_authors><pubmed_authors>Srivastava N</pubmed_authors><pubmed_authors>Srivastava A</pubmed_authors><pubmed_authors>Misra S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Significant role of estrogen and progesterone receptor sequence variants in gallbladder cancer predisposition: a multi-analytical strategy.</name><description>&lt;h4>Background&lt;/h4>Carcinoma of gallbladder (GBC) is an aggressive malignancy. The higher incidence of gallbladder cancer in women has been partly attributed to hormonal factors. Therefore the present study was designed to explore the role of genetic variants in estrogen (ESR1, ESR2) and progesterone (PGR) receptors in conferring risk of gallbladder cancer.&lt;h4>Materials and methods&lt;/h4>The present case-control study recruited total of 860 subjects, including 410 GBC patients, 230 gallstone patients and 220 controls. We examined the associations of 6 selected polymorphisms in three genes: ESR1 (rs2234693, rs9340799, rs1801132), ESR2 (rs1271572, rs1256049) and PGR (rs1042838) with GBC risk. Genotyping for all the polymorphisms was done using PCR-RFLP. Multifactor dimensionality reduction and</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2025-04-22T02:49:45.345Z</modification><creation>2019-03-26T23:18:47Z</creation></dates><accession>S-EPMC3393738</accession><cross_references><pubmed>22808109</pubmed><doi>10.1371/journal.pone.0040162</doi></cross_references></HashMap>